POSEIDA THERAPEUTICS, INC.

Profile

Company Names

POSEIDA THERAPEUTICS, INC.

Addresses

9390 TOWNE CENTRE DRIVE, SUITE 200, SAN DIEGO, CA 92121

4242 CAMPUS POINT COURT, SUITE 700, SAN DIEGO, CA 92121

4250 EXECUTIVE SQUARE, SUITE 900, LA JOLLA, CA 92037

Phone Numbers

858-779-3100
858-242-1576

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$231,813,230.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2023-08-07 
$24,999,999.00 
$24,999,999.00 
$0.00 
Equity 
4
2019-03-19 
$142,120,007.00 
$150,000,000.00 
$7,879,993.00 
Equity 
3
2018-03-19 
$30,499,990.00 
$30,499,990.00 
$0.00 
Equity 
2
2017-07-21 
$11,160,002.00 
$15,000,000.00 
$3,839,998.00 
Equity 
1
2015-12-15 
$23,033,232.00 
$36,033,230.00 
$12,999,998.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RAFAEL 
 
AMADO 
DIRECTOR
POSEIDA THERAPEUTICS, INC.
CHARLES 
M. 
BAUM 
DIRECTOR
POSEIDA THERAPEUTICS, INC.   |  ODYSSEY THERAPEUTICS, INC.
NOAH 
 
BERKOWITZ 
DIRECTOR
POSEIDA THERAPEUTICS, INC.
CYNTHIA 
 
COLLINS 
DIRECTOR
PROVISTA DIAGNOSTICS INC.   |  DERMTECH, INC.   |  POSEIDA THERAPEUTICS, INC.   |  CERTARA, INC.
LUKE 
 
CORNING 
DIRECTOR
POSEIDA THERAPEUTICS, INC.
NISHAN 
 
DE SILVA 
EXECUTIVE OFFICER, DIRECTOR
HANA BIOSCIENCES INC   |  POSEIDA THERAPEUTICS, INC.   |  CARTESIAN THERAPEUTICS, INC.
LARS 
 
EKMAN 
DIRECTOR
ARYX THERAPEUTICS, INC.   |  AMARIN CORP PLC\UK   |  OCERA THERAPEUTICS, INC.   |  POSEIDA THERAPEUTICS, INC.   |  AEOVIAN PHARMACEUTICALS, INC.
MARK 
 
GERGEN 
EXECUTIVE OFFICER, DIRECTOR
APERIO TECHNOLOGIES INC   |  POSEIDA THERAPEUTICS, INC.   |  CERESTI HEALTH, INC.
MARK 
J. 
GERGEN 
EXECUTIVE OFFICER, DIRECTOR
PSYLIN NEUROSCIENCES INC   |  POSEIDA THERAPEUTICS, INC.
DAVID 
 
HIRSCH 
DIRECTOR
NCRX OPTICAL SOLUTIONS INC   |  PRECISION THERAPEUTICS INC   |  TURIYA MEDIA, INC.   |  CIVITAS THERAPEUTICS, INC.   |  COLLEGIUM PHARMACEUTICAL INC   |  SONGZA, INC.   |  RAPID MICRO BIOSYSTEMS, INC.   |  METAMORPHIC VENTURES II, L.P.   |  METAMORPHIC VENTURES II-A, L.P.   |  VOYAT INC.   |  LAUNCHKEY, INC.   |  ONEX YORK CO-INVEST LP   |  COLLEGIUM PHARMACEUTICAL, INC   |  MOVE LOOT, INC.   |  METAMORPHIC VENTURES FD, LLC   |  VELICEPT THERAPEUTICS, INC.   |  GROOP INTERNET PLATFORM INC.   |  ZAVANTE THERAPEUTICS, INC.   |  TRICIDA, INC.   |  MOLECULAR TEMPLATES, INC.   |  POSEIDA THERAPEUTICS, INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  SWIFT HOLDCO LTD   |  WKCGRG HOLDINGS, INC.
ADRIAN 
 
HOWD 
DIRECTOR
VIAMET PHARMACEUTICALS HOLDINGS LLC   |  POSEIDA THERAPEUTICS, INC.
HARRY 
J. 
LEONHARDT 
EXECUTIVE OFFICER
POSEIDA THERAPEUTICS, INC.
MARCEA 
B. 
LLOYD 
DIRECTOR
POSEIDA THERAPEUTICS, INC.
MARCEA 
BLAND 
LLOYD 
DIRECTOR
POSEIDA THERAPEUTICS, INC.
ROBERT 
 
LYONS 
DIRECTOR
HILDENE OPPORTUNITIES OFFSHORE FUND LTD   |  HILDENE OPPORTUNITIES OFFSHORE FUND II, LTD.   |  POSEIDA THERAPEUTICS, INC.   |  HILDENE OPPORTUNITIES OFFSHORE FUND, LTD.   |  CARTER FEDERAL CREDIT UNION
CATHERINE 
J. 
MACKEY 
DIRECTOR
POSEIDA THERAPEUTICS, INC.
SEAN 
 
MURPHY 
DIRECTOR
GAME CREEK FUND LP   |  NOVAN, INC.   |  GAME CREEK OFFSHORE FUND, LTD.   |  KNOW BIO, LLC   |  HARVEST PARTNERS STRUCTURED CAPITAL FUND II, L.P.   |  HARVEST PARTNERS STRUCTURED CAPITAL FUND II (PARALLEL), L.P.   |  XENEX DISINFECTION SERVICES INC.   |  POSEIDA THERAPEUTICS, INC.   |  HARVEST PARTNERS STRUCTURED CAPITAL FUND III (PARALLEL), L.P.   |  HARVEST STRATEGIC ASSOCIATES STRUCTURED CAPITAL FUND III, L.P.   |  HARVEST PARTNERS STRUCTURED CAPITAL FUND III, L.P.   |  TRISALUS LIFE SCIENCES, INC.   |  TRISALUS LIFE SCIENCES, INC.   |  TOGAL.AI, INC.   |  REMCO HOLDINGS LLC
JOHANNA 
M. 
MYLET 
EXECUTIVE OFFICER
POSEIDA THERAPEUTICS, INC.
ERIC 
 
OSTERTAG 
EXECUTIVE OFFICER, DIRECTOR
POSEIDA THERAPEUTICS, INC.   |  HERA TESTING LABORATORIES, INC.
JOHN 
 
SCHMID 
DIRECTOR
TRIUS THERAPEUTICS INC   |  GREEN PARK DENVER, LLC   |  WINPRO PARKING,LLC   |  ANAPTYSBIO INC   |  POSEIDA THERAPEUTICS, INC.   |  DESIGN THERAPEUTICS, INC.   |  BELLWOOD COMMUNITY HOLDING CO.   |  AUTOBOOKS, INC.
MATTHEW 
 
SPEAR 
EXECUTIVE OFFICER
POSEIDA THERAPEUTICS, INC.
BRENT 
 
WARNER 
EXECUTIVE OFFICER
POSEIDA THERAPEUTICS, INC.
KRISTIN 
 
YAREMA 
EXECUTIVE OFFICER
POSEIDA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-08-11
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2023-08-07 
2019-04-22
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-03-19 
2018-04-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-19 
2017-08-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-21 
2015-12-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#